secwatch.observer — SEC 8-K summary
======================================

Issuer:     Calidi Biotherapeutics, Inc. (CLDI)
CIK:        0001855485
Form:       8-K
Filed at:   2026-09-22T21:00:16+00:00
Accession:  0001493152-26-043724
Event type: other_material
Sentiment:  neutral
Materiality: 0.40
Item codes: 1.01, 8.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Calidi Biotherapeutics raises $1.2M in registered direct offering of 1,025,640 shares
--------------------------------------------------------------------------------

- 1,025,640 shares sold at $1.17/share; gross proceeds ~$1.2M.
- Offering closed Sept 21, 2026; no underwriter, placement agent, or discounts.
- Net proceeds for working capital and general corporate purposes.
- Directors and executive officers subject to 60-day lock-up; company agreed to 45-day equity standstill.
- Shares offered via effective Form S-3 shelf (File No. 333-282456).

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1855485/000149315226043724/0001493152-26-043724-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1855485/000149315226043724/form8-k.htm
  HTML page:      https://secwatch.observer/filing/0001493152-26-043724

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer